Organogenesis Holdings (ORGO) Free Cash Flow (Quarterly): -32.75M

Organogenesis Holdings, Inc. (ORGO)

1.29 +0.01 (+0.78%) USD | NASDAQ | Oct 09, 16:00

1.285 0.00 (0.00%) Pre-Market: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2016. Start Trial.

Date	Value
June 30, 2026	-32.75M
March 31, 2026	17.98M
December 31, 2025	34.77M
September 30, 2025	0.844M
June 30, 2025	-36.51M
March 31, 2025	-23.56M
December 31, 2024	7.576M
September 30, 2024	6.126M
June 30, 2024	2.858M
March 31, 2024	-12.38M
December 31, 2023	7.289M
September 30, 2023	10.76M
June 30, 2023	1.147M
March 31, 2023	-12.64M
December 31, 2022	-2.856M
September 30, 2022	-4.949M
June 30, 2022	4.027M
March 31, 2022	-5.261M
December 31, 2021	12.72M
September 30, 2021	11.15M

Date	Value
June 30, 2021	13.33M
March 31, 2021	-6.436M
December 31, 2020	17.80M
September 30, 2020	3.02M
June 30, 2020	-11.50M
March 31, 2020	-21.53M
December 31, 2019	-9.859M
September 30, 2019	-6.728M
June 30, 2019	-13.30M
March 31, 2019	-9.875M
December 31, 2018	-61.87M
September 30, 2018	-0.2867M
June 30, 2018	-0.2101M
March 31, 2018	-0.2264M
December 31, 2017	-0.0918M
September 30, 2017	-0.1687M
June 30, 2017	-0.1997M
March 31, 2017	-0.1263M
December 31, 2016	0.0078M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks